Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Heart Failure × Carvedilol × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Cardiotoxicity 2 Breast Neoplasms 2 Ventricular Dysfunction 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Heart Failure 1 Brain Neoplasms 1

Interventions

pegfilgrastim 1 Vincristine 1 Standard of Care 1 Rituximab 1 Prednisolone 1 Lenalidomide 1 Ivabradine 1 Doxorubicin 1 Dexrazoxane 1 Cyclophosphamide 1 Carvedilol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01724450 2018-02-05

Ceccy

University of Sao Paulo

Phase 3 Completed

Breast Neoplasms, Heart Failure, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡